Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy.

Phase 1

• Conditions: fungal infection; MedDRA version: 9.1Level: LLTClassification code 10017533Term: Fungal infection

• Registration Number: EUCTR2008-007712-14-BE
• Lead Sponsor: Erasme Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-01-07
• Last Update Posted: 14 March 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients receiving posaconazole as prophylaxis of fungal infection and patients treated with posaconazole for a fungal infection.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To evaluate the serum concentrations of posaconazole in patient treated prophylacticaly or as therapy of a fungal infection;Secondary Objective: To determine the factors which influence these concentrations;Primary end point(s):